{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:29:02Z","timestamp":1792636142642,"version":"4.5.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"1","funder":[{"DOI":"10.13039\/100004334","name":"Merck & Co., Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,1,1]]},"DOI":"10.1093\/jac\/dkx353","type":"journal-article","created":{"date-parts":[[2017,9,8]],"date-time":"2017-09-08T15:10:45Z","timestamp":1504883445000},"page":"102-108","source":"Crossref","is-referenced-by-count":46,"title":["Analysis of Clostridium difficile biofilms: imaging and antimicrobial treatment"],"prefix":"10.1093","volume":"73","author":[{"given":"Garth A","family":"James","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Chesnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boegli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elinor","family":"deLancey Pulcini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,10,6]]},"reference":[{"key":"key\n\t\t\t\t20171215014748_dkx353-B1","first-page":"287","article-title":"Clostridium difficile infection","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B2","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","year":"2014","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa1408913","article-title":"Burden of Clostridium difficile infection in the United States","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0195-6701(98)90019-6","article-title":"Risk factors for Clostridium difficile infection","volume":"40","year":"1998","journal-title":"J Hosp Infect"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B5","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1086\/521859","article-title":"Antimicrobial-associated risk factors for Clostridium difficile infection","volume":"46","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B6","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1216064","article-title":"Diverse sources of C. difficile infection identified on whole-genome sequencing","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B7","doi-asserted-by":"crossref","first-page":"397","DOI":"10.4161\/gmic.25862","article-title":"Biofilm formation by Clostridium difficile","volume":"4","year":"2013","journal-title":"Gut Microbes"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B8","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2217\/fmb.12.76","article-title":"Biofilm-specific antibiotic resistance","volume":"7","year":"2012","journal-title":"Future Microbiol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1078\/1438-4221-00196","article-title":"Mechanisms of antibiotic resistance in bacterial biofilms","volume":"292","year":"2002","journal-title":"Int J Med Microbiol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B10","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/jac\/dku116","article-title":"Comparison of planktonic and biofilm-associated communities of Clostridium difficile and indigenous gut microbiota in a triple-stage chemostat gut model","volume":"69","year":"2014","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s10096-015-2323-z","article-title":"Biofilm-specific antibiotic tolerance and resistance","volume":"34","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B12","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1097\/00002480-200011000-00037","article-title":"Role of biofilms in antimicrobial resistance","volume":"46","year":"2000","journal-title":"ASAIO J"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B13","doi-asserted-by":"crossref","first-page":"E36.","DOI":"10.3390\/microorganisms4030036","article-title":"Streptokinase treatment reverses biofilm-associated antibiotic resistance in Staphylococcus aureus","volume":"4","year":"2016","journal-title":"Microorganisms"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B14","doi-asserted-by":"crossref","first-page":"A604","DOI":"10.1289\/ehp.98106a604","article-title":"Studying slime","volume":"106","year":"1998","journal-title":"Environ Health Perspect"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B15","first-page":"Unit 1B.1.","article-title":"Growing and analyzing static biofilms","volume":"1","year":"2005","journal-title":"Curr Protoc Microbiol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B16"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B17","doi-asserted-by":"crossref","first-page":"4494","DOI":"10.1128\/JB.00011-12","article-title":"Daptomycin-mediated reorganization of membrane architecture causes mislocalization of essential cell division proteins","volume":"194","year":"2012","journal-title":"J Bacteriol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B18","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10295-015-1714-6","article-title":"Discovery and development of surotomycin for the treatment of Clostridium difficile","volume":"43","year":"2016","journal-title":"J Ind Microbiol Biotechnol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B19","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1136\/gut.27.10.1169","article-title":"Faecal metronidazole concentrations during oral and intravenous therapy for antibiotic associated colitis due to Clostridium difficile","volume":"27","year":"1986","journal-title":"Gut"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B20","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/1471-2334-10-363","article-title":"Faecal pharmacokinetics of orally administered vancomycin in patients with suspected Clostridium difficile infection","volume":"10","year":"2010","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B21","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1093\/cid\/cis337","article-title":"Fidaxomicin attains high fecal concentrations with minimal plasma concentrations following oral administration in patients with Clostridium difficile infection","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1128\/AAC.47.4.1251-1256.2003","article-title":"Role of nutrient limitation and stationary-phase existence in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin","volume":"47","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B23","doi-asserted-by":"crossref","first-page":"e87757","DOI":"10.1371\/journal.pone.0087757","article-title":"Spore formation and toxin production in Clostridium difficile biofilms","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B24","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/nrmicro2164","article-title":"Clostridium difficile infection: new developments in epidemiology and pathogenesis","volume":"7","year":"2009","journal-title":"Nat Rev Microbiol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B25","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1093\/cid\/cis453","article-title":"Fidaxomicin inhibits spore production in Clostridium difficile","volume":"55","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B26","doi-asserted-by":"crossref","first-page":"e0161200","DOI":"10.1371\/journal.pone.0161200","article-title":"Association of fidaxomicin with C. difficile spores: effects of persistence on subsequent spore recovery, outgrowth and toxin production","volume":"11","year":"2016","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/AAC.01611-12","article-title":"Both fidaxomicin and vancomycin inhibit outgrowth of Clostridium difficile spores","volume":"57","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B29","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B30","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2012.45.5899","article-title":"Resolution of Clostridium difficile-associated diarrhea in patients with cancer treated with fidaxomicin or vancomycin","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000351757","article-title":"Renal impairment and clinical outcomes of Clostridium difficile infection in two randomized trials","volume":"38","year":"2013","journal-title":"Am J Nephrol"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B32","doi-asserted-by":"crossref","first-page":"e88396","DOI":"10.1371\/journal.pone.0088396","article-title":"Development and validation of a chemostat gut model to study both planktonic and biofilm modes of growth of Clostridium difficile and human microbiota","volume":"9","year":"2014","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171215014748_dkx353-B33","doi-asserted-by":"crossref","first-page":"ofw275","DOI":"10.1093\/ofid\/ofw275","article-title":"Primary outcomes from a phase 3, randomized, double-blind, active-controlled trial of surotomycin in subjects with Clostridium difficile infection","volume":"4","year":"2017","journal-title":"Open Forum Infect Dis"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jac\/article-pdf\/73\/1\/102\/22755686\/dkx353.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,17]],"date-time":"2020-10-17T05:15:26Z","timestamp":1602911726000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/jac\/article\/73\/1\/102\/4364867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,6]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,10,6]]},"published-print":{"date-parts":[[2018,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkx353","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,1]]},"published":{"date-parts":[[2017,10,6]]}}}